REBECCA PARKER: Open Payments
NPI 1639610512 · VA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$232 in 7 payments from 4 companies in 2025. Trend: 2023 $443 · 2024 $400 · 2025 $232
Food & beverage: $232
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 1 | $125 |
| Novo Nordisk Inc | 3 | $62 |
| Amgen Inc. | 2 | $30 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: Leqembi, Ozempic, OTEZLA, SHINGRIX, REPATHA.
Industry payments across VA — which companies pay providers there.
